Citation Impact
Citing Papers
Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan
2011
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Characterizing IgG4-related disease with 18F-FDG PET/CT: a prospective cohort study
2014
Cardiac involvement and treatment-related mortality after non-myeloablative haemopoietic stem-cell transplantation with unselected autologous peripheral blood for patients with systemic sclerosis: a retrospective analysis
2013
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
2005 Standout
NF-κB, the first quarter-century: remarkable progress and outstanding questions
2012 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Rheumatoid Arthritis by Bioinformatics Analysis
2021
Inflammation as a tumor promoter in cancer induction
2004
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Systemic sclerosis
2017 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
IgG4-related disease
2014 Standout
BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription
2006
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance
2009 Standout
The IKK Inhibitor Bay 11-7082 Induces Cell Death Independent from Inhibition of Activation of NFκB Transcription Factors
2013
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status
2014
Antitumoral and antileishmanial dioncoquinones and ancistroquinones from cell cultures of Triphyophyllum peltatum (Dioncophyllaceae) and Ancistrocladus abbreviatus (Ancistrocladaceae)
2008
Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors
2004
Age Sensitivity of NFκB Abundance and Programmed Cell Death in Erythrocytes Induced by NFκB Inhibitors
2013 Standout
The role of IL-6 and STAT3 in inflammation and cancer
2005 Standout
L‐asparaginase treatment in acute lymphoblastic leukemia
2010
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses
2022 StandoutNobel
Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors
2010
The IL-6 receptor antagonist SANT-7 overcomes bone marrow stromal cell-mediated drug resistance of multiple myeloma cells
2001
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
MLN120B, a Novel IκB Kinase β Inhibitor, Blocks Multiple Myeloma Cell Growth In vitro and In vivo
2006
Combined disruption of both the MEK/ERK and the IL-6R/STAT3 pathways is required to induce apoptosis of multiple myeloma cells in the presence of bone marrow stromal cells
2004
Clinical and Histopathological Features of Patients with Systemic Sclerosis Undergoing Endomyocardial Biopsy
2015
Natural product and natural product derived drugs in clinical trials
2014 Standout
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma
2010
Perspectives on medicinal properties of plumbagin and its analogs
2010 Standout
Works of Marc Schmalzing being referenced
Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestations
2014
Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia
2012
Optimization of Autologous Stem Cell Transplantation for Systemic Sclerosis — A Single-center Longterm Experience in 26 Patients with Severe Organ Manifestations
2012
Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytoma
2001
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
2005
PEG-Asparaginase in Adult Acute Lymphoblastic Leukemia (ALL): Efficacy and Feasibility Analysis with Increasing Dose Levels
2008
Systemic IgG4-Related Sclerosing Disease: Spectrum of Imaging Findings and Differential Diagnosis
2012
T cells, natural killer cells, and γδT cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapy
2019